Suppr超能文献

小儿肾移植中避免使用类固醇的临床实践

Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation.

作者信息

Nehus E, Liu C, Hooper D K, Macaluso M, Kim M-O

机构信息

Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.

出版信息

Am J Transplant. 2015 Aug;15(8):2203-10. doi: 10.1111/ajt.13270. Epub 2015 Apr 23.

Abstract

Steroid-avoidance protocols have recently gained popularity in pediatric kidney transplantation. We investigated the clinical practice of steroid avoidance among 9494 kidney transplant recipients at 124 transplant centers between 2000 and 2012 in the Organ Procurement and Transplantation Network database. The practice of steroid avoidance increased during the study period and demonstrated significant variability among transplant centers. From 2008 to 2012, 39% of transplant centers used steroid avoidance in <10% of all discharged transplant recipients. Twenty-one percent of transplant centers practiced steroid avoidance in 10-40% of transplant recipients, and 40% of transplant centers used steroid avoidance in >40% of discharged patients. Children receiving steroid avoidance more frequently received induction with lymphocyte-depleting agents. Repeat kidney transplants were the least likely to receive steroid avoidance. Children who received a deceased donor kidney, underwent pretransplant dialysis, were highly sensitized, or had glomerular kidney disease or delayed graft function were also less likely to receive steroid avoidance. The variation in practice between centers remained highly significant (p < 0.0001) after adjustment for all patient- and center-level factors in multivariate analysis. We conclude that significant differences in the practice of steroid avoidance among transplant centers remain unexplained and may reflect uncertainty about the safety and efficacy of steroid-avoidance protocols.

摘要

在小儿肾移植中,避免使用类固醇的方案近来颇受关注。我们在器官获取与移植网络数据库中,调查了2000年至2012年间124个移植中心的9494例肾移植受者中避免使用类固醇的临床实践情况。在研究期间,避免使用类固醇的做法有所增加,且各移植中心之间存在显著差异。从2008年到2012年,39%的移植中心在所有出院的移植受者中,使用避免类固醇方案的比例不到10%。21%的移植中心在10%至40%的移植受者中采用了避免类固醇方案,40%的移植中心在超过40%的出院患者中使用了该方案。接受避免类固醇方案的儿童更频繁地接受淋巴细胞清除剂诱导治疗。再次肾移植受者最不可能接受避免类固醇方案。接受 deceased 供体肾脏、术前接受透析、高度致敏、患有肾小球肾病或移植肾功能延迟的儿童也不太可能接受避免类固醇方案。在多变量分析中,对所有患者和中心层面的因素进行调整后,各中心之间的实践差异仍然非常显著(p < 0.0001)。我们得出结论,移植中心之间在避免使用类固醇的实践上存在显著差异,其原因尚不清楚,这可能反映了对避免类固醇方案的安全性和有效性存在不确定性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验